| Literature DB >> 12536127 |
David Colman1, Catherine Lubetzki, Stephen Reingold.
Abstract
Multiple sclerosis (MS) is an inflammatory demyelinating disease of the CNS, affecting approximately 1/1000 individuals in the Western world. Available treatments limit CNS inflammation and strategies to repair damage in the CNS offer the potential of recovery of both tissue and function. With further fundamental knowledge developing, this area is ripe for 'translation' to clinical application.Entities:
Mesh：
Substances：
Year: 2003 PMID： 12536127 DOI： 10.1016/s0166-2236(02)00015-2
Source DB: PubMed Journal: Trends Neurosci ISSN： 0166-2236 Impact factor: 13.837